Analyst Ratings for Singular Genomics (OMIC)

OMIC Rating Summary

  |   Expand Research on OMIC
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2 / 10   Percentile Rank: 15%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/17/2022 UBS
» Updated 3/20/2024		 John Sourbeer Downgrade Neutral
(Buy)		 0.50
(0.40)		 4.31
(20.01)		 364.27% Details
8/10/2022 JPMorgan Tycho W. Peterson Downgrade Neutral
(Overweight)		 N/A
(N/A)		 4.45
(20.01)		 349.66% Details